Studies reveal the promise of newly engineered bispecific antibodies against tumor cells

By | March 2, 2021
Three studies – one each in Science, Science Translational Medicine, and Science Immunology – reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases.